Addition of a total pancreatectomy and pancreas transplantation in a liver transplant recipient with intraductal papillary mucinous neoplasm of the pancreas

Jonathan A. Fridell, Rodrigo Vianna, Richard Mangus, Marwan Kazimi, Edward Hollinger, A. Joseph Tector

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are increasingly recognized in clinical practice. There are no published data suggesting a management approach for the potential organ transplant recipient with the incidental finding of this pre-malignant lesion. Method: The recipient was a 65-yr-old man with hepatocellular carcinoma in a background of Laennec's cirrhosis. During evaluation for transplant, he was found to have diffuse IPMN. This patient underwent liver transplantation with a planned simultaneous total native pancreatectomy and pancreas transplant from the same donor. Results: The patient has had normal liver function and has been free of diabetes and exocrine insufficiency at 18 months post-transplant. Conclusion: IPMN in the potential transplant recipient should be managed more aggressively than in the general population because these patients will be committed to life-long immunosuppression. If a total pancreatectomy is contemplated, this is a unique opportunity to replace the pancreas with an allograft at the time of transplantation.

Original languageEnglish
Pages (from-to)681-684
Number of pages4
JournalClinical Transplantation
Volume22
Issue number5
DOIs
StatePublished - 2008

Fingerprint

Pancreas Transplantation
Pancreatectomy
Pancreatic Neoplasms
Transplants
Liver
Pancreas
Incidental Findings
Liver Transplantation
Immunosuppression
Allografts
Hepatocellular Carcinoma
Neoplasms
Fibrosis
Transplantation
Tissue Donors
Transplant Recipients
Population

ASJC Scopus subject areas

  • Transplantation

Cite this

Addition of a total pancreatectomy and pancreas transplantation in a liver transplant recipient with intraductal papillary mucinous neoplasm of the pancreas. / Fridell, Jonathan A.; Vianna, Rodrigo; Mangus, Richard; Kazimi, Marwan; Hollinger, Edward; Joseph Tector, A.

In: Clinical Transplantation, Vol. 22, No. 5, 2008, p. 681-684.

Research output: Contribution to journalArticle

Fridell, Jonathan A. ; Vianna, Rodrigo ; Mangus, Richard ; Kazimi, Marwan ; Hollinger, Edward ; Joseph Tector, A. / Addition of a total pancreatectomy and pancreas transplantation in a liver transplant recipient with intraductal papillary mucinous neoplasm of the pancreas. In: Clinical Transplantation. 2008 ; Vol. 22, No. 5. pp. 681-684.
@article{87884c3f467541f49b2c0875e8dcb7d1,
title = "Addition of a total pancreatectomy and pancreas transplantation in a liver transplant recipient with intraductal papillary mucinous neoplasm of the pancreas",
abstract = "Background: Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are increasingly recognized in clinical practice. There are no published data suggesting a management approach for the potential organ transplant recipient with the incidental finding of this pre-malignant lesion. Method: The recipient was a 65-yr-old man with hepatocellular carcinoma in a background of Laennec's cirrhosis. During evaluation for transplant, he was found to have diffuse IPMN. This patient underwent liver transplantation with a planned simultaneous total native pancreatectomy and pancreas transplant from the same donor. Results: The patient has had normal liver function and has been free of diabetes and exocrine insufficiency at 18 months post-transplant. Conclusion: IPMN in the potential transplant recipient should be managed more aggressively than in the general population because these patients will be committed to life-long immunosuppression. If a total pancreatectomy is contemplated, this is a unique opportunity to replace the pancreas with an allograft at the time of transplantation.",
author = "Fridell, {Jonathan A.} and Rodrigo Vianna and Richard Mangus and Marwan Kazimi and Edward Hollinger and {Joseph Tector}, A.",
year = "2008",
doi = "10.1111/j.1399-0012.2008.00863.x",
language = "English",
volume = "22",
pages = "681--684",
journal = "Clinical Transplantation",
issn = "0902-0063",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Addition of a total pancreatectomy and pancreas transplantation in a liver transplant recipient with intraductal papillary mucinous neoplasm of the pancreas

AU - Fridell, Jonathan A.

AU - Vianna, Rodrigo

AU - Mangus, Richard

AU - Kazimi, Marwan

AU - Hollinger, Edward

AU - Joseph Tector, A.

PY - 2008

Y1 - 2008

N2 - Background: Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are increasingly recognized in clinical practice. There are no published data suggesting a management approach for the potential organ transplant recipient with the incidental finding of this pre-malignant lesion. Method: The recipient was a 65-yr-old man with hepatocellular carcinoma in a background of Laennec's cirrhosis. During evaluation for transplant, he was found to have diffuse IPMN. This patient underwent liver transplantation with a planned simultaneous total native pancreatectomy and pancreas transplant from the same donor. Results: The patient has had normal liver function and has been free of diabetes and exocrine insufficiency at 18 months post-transplant. Conclusion: IPMN in the potential transplant recipient should be managed more aggressively than in the general population because these patients will be committed to life-long immunosuppression. If a total pancreatectomy is contemplated, this is a unique opportunity to replace the pancreas with an allograft at the time of transplantation.

AB - Background: Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are increasingly recognized in clinical practice. There are no published data suggesting a management approach for the potential organ transplant recipient with the incidental finding of this pre-malignant lesion. Method: The recipient was a 65-yr-old man with hepatocellular carcinoma in a background of Laennec's cirrhosis. During evaluation for transplant, he was found to have diffuse IPMN. This patient underwent liver transplantation with a planned simultaneous total native pancreatectomy and pancreas transplant from the same donor. Results: The patient has had normal liver function and has been free of diabetes and exocrine insufficiency at 18 months post-transplant. Conclusion: IPMN in the potential transplant recipient should be managed more aggressively than in the general population because these patients will be committed to life-long immunosuppression. If a total pancreatectomy is contemplated, this is a unique opportunity to replace the pancreas with an allograft at the time of transplantation.

UR - http://www.scopus.com/inward/record.url?scp=52649145308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52649145308&partnerID=8YFLogxK

U2 - 10.1111/j.1399-0012.2008.00863.x

DO - 10.1111/j.1399-0012.2008.00863.x

M3 - Article

C2 - 18627400

AN - SCOPUS:52649145308

VL - 22

SP - 681

EP - 684

JO - Clinical Transplantation

JF - Clinical Transplantation

SN - 0902-0063

IS - 5

ER -